Shinpoong will conduct phase 2 clinical trials of Pyramax again to prove its safety and effectiveness as a treatment for COVID-19. On the 13th, the MFDS approved a clinical trial to explore the safety and effectiveness of Pyramax in patients with mild or moderate COVID-19.

Exploratory clinical trials are clinical trials conducted for the purpose of collecting initial safety and validity information of drugs, designing subsequent clinical trials, providing evidence for evaluation items, and evaluation methods, and are conducted over a relatively short period of time for a few subjects.

Since June 2020, Shinpoong has conducted randomized, double-blind, parallel, placebo-controlled, and phas